Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population

Vaccine

Volumn 30, Issue 6, 2012, Pages 1101-1107

  Matsushita, Masahide ^a   Takeuchi, Seisho ^a   Kumagai, Naoko ^a   Uehara, Yoshio ^a   Matsushita, Chise ^b   Arise, Kazumi ^a   Seo, Hiromi ^a   Awatani, Toshihide ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b Department of Internal Medicine   (Japan)

Author keywords

Antibody titers; Influenza vaccine; Rural community dwelling elderly persons; Seroprotection rate

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; COMMUNITY LIVING; FEMALE; GERIATRICS; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA; SEROLOGY;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RURAL POPULATION; TIME FACTORS; VACCINATION;

EID: 84856322641     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.024     Document Type: Article

References (21)

1. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
2. Smith N.M., Bresee J.S., Shay D.K., Uyeki T.M., Cox N.J., Strikas R.A. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR 2006, 55:1-42.
3. Clements M.L., Betts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986, 24:157-160.
4. Govaert M.E., Thijs C.T.M.C., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-1665.
5. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995, 123:518-527.
6. Voordouw B.C.G., van der Linden P.D., Simonian S., van der Lei J., Sturkenboom M.C.J.M., Stricker B.H.C. Influenza vaccination in community-dwelling elderly. Impact on mortality and influenza-associated morbidity. Arch Intern Med 2003, 163:1089-1094.
7. Simonsen L., Reichert T.A., Viboud C., Blackwelder W.C., Taylor R.J., Miller M.A. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005, 165:265-272.
8. McElhaney J.E., Beattie B.L., Devine R., Grynoch R., Toth E.L., Bleackley R.C. Age-related decline in interleukin 2 production in response to influenza vaccine. J Am Geriatr Soc 1990, 38:652-658.
9. Dorrell L., Hassan I., Marshall S., Chakraverty P., Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS 1997, 8:776-779.
10. Sato M., Saito R., Tanabe N., Nishikawa M., Sasaki A., Gejyo F., et al. Antibody response to influenza vaccination in nursing home residents and healthcare workers during four successive seasons in Niigata, Japan. Infect Control Hosp Epidemiol 2005, 26:859-866.
11. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
12. Hui S.L., Chu L.W., Peiris J.S.M., Chan K.H., Chu D., Tsui W. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Vaccine 2006, 24:5371-5380.
13. Gross P.A., Russo C., Teplitzky M., Dran S., Cataruozolo P., Munk G. Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 1996, 3:361-362.
14. Brydak L.B., Machala M., Myśliwska J., MyŚliwski A., Trzonkowski P. Immune response to influenza vaccination in an elderly population. J Clin Immunol 2003, 23:214-222.
15. Zambon M. Laboratory diagnosis of influenza. Text book of influenza 1998, 291-313. Blackwell Science, Oxford. K.G. Nicholson, R.G. Webster, A.J. Hay (Eds.).
16. Künzel W., Glathe H., Engelmann H., Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996, 14:1108-1110.
17. Beyer W.E.P., Palache A.M., Luchters G., Nauta J., Osterhaus A. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res 2004, 103:125-132.
18. Gardner E.M., Bernstein E.D., Dran S., Munk G., Abrutyn E., Murasko D.M. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine 2001, 19:4610-4617.
19. Skowronski D.M., Tweed S.A., De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 2008, 197:490-502.
20. Hara M., Tanaka K., Hirota Y. Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine 2005, 23:1457-1463.
21. Sasaki S., Sullivan M., Narvaez C.F., Holmes T.H., Furman D., Zheng N.Y., et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011, 121:3109-3119.